These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
179 related items for PubMed ID: 9832443
1. p70 S6 kinase activation is not required for insulin-like growth factor-induced differentiation of rat, mouse, or human skeletal muscle cells. Canicio J, Gallardo E, Illa I, Testar X, Palacín M, Zorzano A, Kaliman P. Endocrinology; 1998 Dec; 139(12):5042-9. PubMed ID: 9832443 [Abstract] [Full Text] [Related]
2. Insulin-like growth factors require phosphatidylinositol 3-kinase to signal myogenesis: dominant negative p85 expression blocks differentiation of L6E9 muscle cells. Kaliman P, Canicio J, Shepherd PR, Beeton CA, Testar X, Palacín M, Zorzano A. Mol Endocrinol; 1998 Jan; 12(1):66-77. PubMed ID: 9440811 [Abstract] [Full Text] [Related]
3. Up-regulation of insulin-like growth factor binding protein-5 is independent of muscle cell differentiation, sensitive to rapamycin, but insensitive to wortmannin and LY294002. Rousse S, Montarras D, Pinset C, Dubois C. Endocrinology; 1998 Apr; 139(4):1487-93. PubMed ID: 9528925 [Abstract] [Full Text] [Related]
4. The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. Coolican SA, Samuel DS, Ewton DZ, McWade FJ, Florini JR. J Biol Chem; 1997 Mar 07; 272(10):6653-62. PubMed ID: 9045696 [Abstract] [Full Text] [Related]
5. Activation of phosphatidylinositol 3-kinase, protein kinase B, and p70 S6 kinases in lipopolysaccharide-stimulated Raw 264.7 cells: differential effects of rapamycin, Ly294002, and wortmannin on nitric oxide production. Salh B, Wagey R, Marotta A, Tao JS, Pelech S. J Immunol; 1998 Dec 15; 161(12):6947-54. PubMed ID: 9862729 [Abstract] [Full Text] [Related]
6. Phosphatidylinositol 3-kinase and p70 s6 kinase participate in the regulation of protein turnover in skeletal muscle by insulin and insulin-like growth factor I. Dardevet D, Sornet C, Vary T, Grizard J. Endocrinology; 1996 Oct 15; 137(10):4087-94. PubMed ID: 8828461 [Abstract] [Full Text] [Related]
7. Insulin-like growth factor-II, phosphatidylinositol 3-kinase, nuclear factor-kappaB and inducible nitric-oxide synthase define a common myogenic signaling pathway. Kaliman P, Canicio J, Testar X, Palacín M, Zorzano A. J Biol Chem; 1999 Jun 18; 274(25):17437-44. PubMed ID: 10364173 [Abstract] [Full Text] [Related]
8. Temporal activation of p70 S6 kinase and Akt1 by insulin: PI 3-kinase-dependent and -independent mechanisms. Somwar R, Sumitani S, Taha C, Sweeney G, Klip A. Am J Physiol; 1998 Oct 18; 275(4):E618-25. PubMed ID: 9755080 [Abstract] [Full Text] [Related]
9. Involvement of the rapamycin-sensitive pathway in the insulin regulation of muscle protein synthesis in streptozotocin-diabetic rats. Grzelkowska K, Dardevet D, Balage M, Grizard J. J Endocrinol; 1999 Jan 18; 160(1):137-45. PubMed ID: 9854185 [Abstract] [Full Text] [Related]
10. Growth hormone and the insulin-like growth factor system in myogenesis. Florini JR, Ewton DZ, Coolican SA. Endocr Rev; 1996 Oct 18; 17(5):481-517. PubMed ID: 8897022 [Abstract] [Full Text] [Related]
11. Permissive roles of phosphatidyl inositol 3-kinase and Akt in skeletal myocyte maturation. Wilson EM, Tureckova J, Rotwein P. Mol Biol Cell; 2004 Feb 18; 15(2):497-505. PubMed ID: 14595115 [Abstract] [Full Text] [Related]
12. Stress-activated protein kinase-2/p38 and a rapamycin-sensitive pathway are required for C2C12 myogenesis. Cuenda A, Cohen P. J Biol Chem; 1999 Feb 12; 274(7):4341-6. PubMed ID: 9933636 [Abstract] [Full Text] [Related]
13. Phosphatidylinositol 3-kinase inhibitors block differentiation of skeletal muscle cells. Kaliman P, Viñals F, Testar X, Palacín M, Zorzano A. J Biol Chem; 1996 Aug 09; 271(32):19146-51. PubMed ID: 8702591 [Abstract] [Full Text] [Related]
14. Involvement of phosphoinositide-3-kinase and p70 S6 kinase in regulation of proliferation of rat lactotrophs in culture. Kawashima K, Yamakawa K, Arita J. Endocrine; 2000 Dec 09; 13(3):385-92. PubMed ID: 11216652 [Abstract] [Full Text] [Related]
15. Effects of insulin like growth factors on early embryonic chick limb myogenesis. Mohammed RH, Anderton H, Brameld JM, Sweetman D. PLoS One; 2017 Dec 09; 12(10):e0185775. PubMed ID: 28972999 [Abstract] [Full Text] [Related]
16. Muscle-specific overexpression of the type 1 IGF receptor results in myoblast-independent muscle hypertrophy via PI3K, and not calcineurin, signaling. Quinn LS, Anderson BG, Plymate SR. Am J Physiol Endocrinol Metab; 2007 Dec 09; 293(6):E1538-51. PubMed ID: 17940216 [Abstract] [Full Text] [Related]
17. Insulin-like growth factors (IGF-I and IGF-II) inhibit C2 skeletal myoblast differentiation and enhance TNF alpha-induced apoptosis. Foulstone EJ, Meadows KA, Holly JM, Stewart CE. J Cell Physiol; 2001 Nov 09; 189(2):207-15. PubMed ID: 11598906 [Abstract] [Full Text] [Related]
18. Phosphatidylinositol 3-kinase, protein kinase B and ribosomal S6 kinases in the stimulation of thyroid epithelial cell proliferation by cAMP and growth factors in the presence of insulin. Coulonval K, Vandeput F, Stein RC, Kozma SC, Lamy F, Dumont JE. Biochem J; 2000 Jun 01; 348 Pt 2(Pt 2):351-8. PubMed ID: 10816429 [Abstract] [Full Text] [Related]
19. Raf-1 activation stimulates proliferation and inhibits IGF-stimulated differentiation in L6A1 myoblasts. Samuel DS, Ewton DZ, Coolican SA, Petley TD, McWade FJ, Florini JR. Horm Metab Res; 1999 Jun 01; 31(2-3):55-64. PubMed ID: 10226782 [Abstract] [Full Text] [Related]
20. Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells. Halevy O, Cantley LC. Exp Cell Res; 2004 Jul 01; 297(1):224-34. PubMed ID: 15194438 [Abstract] [Full Text] [Related] Page: [Next] [New Search]